1. Executive Summary

The history of medication reconciliation (MedRec) represents a pivotal journey in healthcare’s commitment to patient safety and quality of care. Originating from informal, often fragmented medication management practices, the process evolved dramatically in response to a growing awareness of medication errors and adverse drug events (ADEs). The seminal 1999 “To Err Is Human” report by the Institute of Medicine served as a critical catalyst, shifting the focus from individual blame to systemic accountability and prompting regulatory bodies like The Joint Commission to mandate formal reconciliation processes. Concurrently, global initiatives such as the WHO High 5s Project further underscored the universal imperative for medication accuracy at transitions of care. This historical progression has seen a transformative shift from manual, error-prone methods to sophisticated digital integrations within Electronic Health Records (EHRs), redefining the roles and fostering interdisciplinary collaboration among healthcare professionals. While formalized MedRec has demonstrably reduced medication errors, ADEs, and healthcare costs, persistent challenges related to systemic complexities, workflow integration, and IT limitations necessitate continuous adaptation and innovation. The ongoing evolution of medication reconciliation stands as a testament to the healthcare system’s dynamic pursuit of enhanced patient safety and the ultimate goal of zero harm in medication management.

2. Introduction: Defining Medication Reconciliation and Its Critical Role

Medication reconciliation is a cornerstone of modern patient safety, a formalized process designed to prevent medication errors and ensure continuity of care across various healthcare settings. At its core, medication reconciliation is defined by The Joint Commission as “the process of comparing a patient’s medication orders to all of the medications that the patient has been taking”.¹ This meticulous comparison is undertaken with the explicit purpose of actively avoiding common medication errors, including omissions, duplications, incorrect dosing, or adverse drug interactions.¹

The fundamental objective of this process extends beyond a simple comparison of lists. It involves the creation of “the most accurate list possible of all medications a patient is taking – including a drug name, dosage, frequency and route – and comparing that list against the physician’s admission, transfer, and/or discharge orders”.² The overarching aim is to ensure that patients receive the correct medications at every transition of care, thereby safeguarding patient well-being and maintaining the integrity of their treatment regimen.² This definition underscores the clinician’s active and crucial role in comparing medication lists to identify and resolve discrepancies, differentiating it from the mere act of gathering a medication history.²

The evolving understanding of medication reconciliation reflects a significant maturation in healthcare’s approach to patient safety. Initial conceptualizations focused primarily on the comparison of medication orders with a patient’s existing regimen to prevent errors.¹ However, the current emphasis explicitly highlights the importance of the reconciliation process as an active intervention by a clinician to identify and resolve discrepancies, rather than simply compiling a list of medications.² This progression in definition signals a profound philosophical shift in healthcare, moving from passive data collection to proactive error prevention. It underscores the growing recognition of medication reconciliation as a critical patient safety intervention, directly linking the rigor of the process to tangible patient outcomes.

Furthermore, medication reconciliation is not a continuous, ambient process but a strategically targeted intervention, primarily focused on “vulnerable moments” in patient care. The consistent identification of admission, transfer, and discharge orders as key comparison points ², and the broader application to “every transition of care” ³, indicates a deliberate focus on high-risk periods. Transitions of care are inherently susceptible to communication breakdowns, information loss, and subsequent medication errors. The formal process of medication reconciliation is thus specifically designed to mitigate these known systemic vulnerabilities, representing a strategic approach to patient safety that acknowledges these specific junctures as points where patients are most susceptible to medication discrepancies and potential harm.

3. The Genesis of Medication Management: Pre-Formal Reconciliation Practices

The fundamental need to manage and document medicinal treatments is deeply rooted in human history, long predating the formal concept of medication reconciliation. The earliest known prescriptions were inscribed on clay tablets in Mesopotamia around 2400 BC.⁴ Ancient Egyptian pharmacological knowledge was also extensively documented, notably in the Ebers Papyrus of 1550 BC, which provided detailed medical recommendations.⁵ In the 1st century AD, China saw the compilation of the Shennong Ben Cao Jing, an early manual on materia medica.⁶ The advent of the printing press in the 15th century further facilitated the spread of medicinal textbooks and formularies, with the Antidotarium being recognized as the first printed drug formulary.⁶ While these historical records demonstrate an ancient recognition of the importance of medication information, the systematic and reliable management of this information, particularly in complex patient care scenarios, remained a significant challenge for centuries. The increasing complexity of modern polypharmacy and healthcare transitions ultimately necessitated a more formal, structured approach to medication management.

Prior to the formalization of medication reconciliation, healthcare workflows were often characterized by informal and fragmented practices. Physicians and nurses traditionally did not routinely conduct a comprehensive inventory or verification of all medications a patient was taking, which included not only prescription drugs but also over-the-counter medications, herbal remedies, and other complementary therapies.³ A notable absence of standardization meant there was no consistent definition of what constituted a comprehensive medication history, nor was there a designated, consistent location for this information within paper or early electronic health records. As a result, a patient’s medication history could be scattered across various sources, such as the nursing admission database, the medication administration record, the physician’s history, or the pharmacy profile.³ This lack of standardization led to considerable variation in how historical medication information was gathered, the sources consulted, the comprehensiveness of medication orders, and how this critical information was communicated across different care settings.³

These informal methods inherently carried significant limitations, leading to high error rates in medication histories. Studies from this period revealed that the frequency of at least one error in medication histories ranged from 27% to 83%, and even when considering only prescription medications, the error rate was between 10% and 67%. The number of medication errors could vary from 0.3 to 2.7 per patient.⁷ More specifically, 50–67% of medication histories were found to contain errors, often due to the inclusion of medications the patient had discontinued or the omission of currently taken medications.⁸ This problem was particularly pronounced in geriatric patients, with errors identified in up to 81% of their medication histories.⁸

The root causes of these inaccuracies were multifaceted. Common barriers to obtaining accurate histories included time constraints and busy clinical environments, inadequate training of staff in medication history-taking skills, and challenges related to patient recall or their limited knowledge of their own medication regimens.³ Patients frequently did not bring their medication bottles to the hospital or maintain accurate, updated lists, and family members, while helpful, were not always reliable historians.³ These high error rates observed in pre-formal reconciliation were not random occurrences but direct consequences of a healthcare system that lacked standardized processes, sufficient training, and integrated information flow. This systemic vulnerability, where pressures like time constraints and inadequate training combined with inherent human limitations, created an environment highly susceptible to medication errors. This understanding provides a compelling rationale for the later regulatory push and the development of formal, multidisciplinary medication reconciliation processes.

4. A Turning Point: The Patient Safety Movement and “To Err Is Human”

The late 20th century marked a critical juncture in healthcare, as escalating concerns about medical errors brought them to the forefront of public health discourse. In the United States, medication errors alone were estimated to cause harm to 1.5 million individuals and result in several thousand deaths annually, incurring a substantial economic burden of at least $3.5 million each year.⁹ The severity of this issue was starkly highlighted by the fact that deaths attributed to medical errors surpassed those from motor vehicle accidents, breast cancer, or AIDS. Alarmingly, they even exceeded the number of deaths from suicide, which at the time was the eighth-leading cause of death.¹¹ This significant disparity between the actual incidence of medical errors and public perception underscored a critical and urgent problem that demanded systemic attention.¹²

This growing awareness culminated in a pivotal moment with the publication of “To Err Is Human: Building a Safer Health System” in November 1999 by the Institute of Medicine (IOM), now known as the National Academy of Medicine. This seminal report dramatically increased awareness of medical errors across the U.S. healthcare landscape.¹¹ Crucially, the report fundamentally reframed the understanding of medical errors, emphasizing that the majority were the result of “failures of the system rather than specifically attributable to individuals”.¹¹ It powerfully asserted that “the problem is not bad people in health care–it is that good people are working in bad systems that need to be made safer”.¹² This systemic perspective was instrumental in shifting the focus from individual blame to the design of safer processes and environments.

The “To Err Is Human” report served as a powerful catalyst for change, calling for fundamental transformations in the healthcare system to enhance patient safety and quality of care.¹¹ It marked a pivotal moment where attention rapidly shifted from a primary focus on innovation to a heightened emphasis on safety, a shift that has since provided “enormous benefits to our patients”.¹¹ The report’s success in elevating patient safety to a national priority demonstrates the profound influence of compelling, evidence-based advocacy. By framing medical errors as a significant, yet largely unacknowledged, public health crisis, the report generated a sense of urgency and political will that had been lacking. This public and professional awakening directly led to increased funding, research, and regulatory mandates for safety initiatives, including the formal adoption and emphasis on medication reconciliation as a core strategy to mitigate preventable harm. This paradigm shift was foundational for the patient safety movement, creating the necessary intellectual and cultural space for healthcare organizations and regulatory bodies to implement system-level interventions, such as medication reconciliation, without being perceived as punitive. It acknowledged that human error is inevitable in complex systems, and therefore, systems must be designed to catch and prevent errors before they cause harm.

5. Standardization and Regulation: The Joint Commission and Global Initiatives

The formalization of medication reconciliation as a critical patient safety process was significantly driven by regulatory bodies and international organizations, aiming to standardize practices and reduce medication-related harm. In the United States, The Joint Commission (TJC) played a pivotal role by establishing medication reconciliation as a National Patient Safety Goal (NPSG). It was initially introduced as the eighth NPSG in 2004, with compliance surveys commencing in 2006, specifically designed to promote medication safety.⁹

However, the complexity of implementing comprehensive medication reconciliation processes posed considerable challenges for many healthcare organizations. Recognizing these difficulties, TJC temporarily ceased surveying for compliance in 2009.⁹ Following a period of re-evaluation, medication reconciliation was re-designated as the third National Patient Safety Goal in September 2011, as part of the Comprehensive Accreditation Manual for Hospitals Update 2.⁹ The revised intent of this goal emphasized a “good faith effort” from facilities in collecting a patient’s current medication list.⁹ This regulatory “push-and-pull” reflects the immense practical challenges of integrating such a complex process into diverse and often resistant healthcare environments. The oscillation between strict mandate and a more pragmatic “good faith effort” highlights a tension between aspirational safety goals and operational realities, indicating that policy mandates alone are often insufficient for driving complex quality improvements. Successful implementation requires a nuanced understanding of systemic barriers, workflow complexities, and cultural resistance.

Joint Commission standards mandate that medication reconciliation occur at several critical junctures in patient care. These include upon hospital entry or admission, upon transfer within the facility, upon transfer to another facility or discharge home, and in hospital areas with short patient contact.⁹ The process requires the collection of information including dosage, route, and frequency, with active involvement of the patient and/or family in obtaining this data.⁹ Furthermore, all medications ordered during hospitalization must be rigorously compared with the initial list to prevent duplications, omissions, adjustments, or contraindications.⁹

Beyond national efforts, global harmonization initiatives have reinforced the universal recognition of medication safety imperatives. The World Health Organization (WHO) developed the International High 5s Project to address major global concerns about patient safety.¹³ Medication reconciliation is a core component of this project, defined as a formal process in which healthcare professionals partner with patients to ensure accurate and complete medication information transfer at all interfaces of care.¹⁴ The driving force behind the WHO High 5s medication reconciliation initiative is the prevention of adverse drug events by reducing undocumented discrepancies as patients transition between different levels of care.¹³

The WHO High 5s Project outlines key guiding principles for effective medication reconciliation. These include maintaining an accurate patient medication list, implementing a formal structured process, recognizing admission reconciliation as foundational for subsequent transitions, ensuring shared accountability among all staff involved, integrating the process into existing workflows rather than treating it as an “add-on,” actively involving patients and families, and ensuring that staff are adequately trained.¹⁴ The project emphasizes obtaining a “Best Possible Medication History (BPMH)” from multiple sources, such as patient/family interviews, community pharmacists, physicians, and government databases. It also provides core measures for evaluating implementation success, such as the percentage of patients with medications reconciled within 24 hours and the mean number of outstanding unintentional discrepancies.¹⁴ French experimentation with the WHO High 5s project from 2010 to 2014 demonstrated the effectiveness of this approach, with a mean of 0.9 intercepted and corrected medication errors per patient, all successfully resolved through collaborative exchange between pharmacists and physicians.¹³ The widespread adoption of medication reconciliation principles by international bodies like the WHO demonstrates a global consensus on the criticality of this process. The shared guiding principles indicate that the challenges of medication safety and the fundamental solutions are not unique to one country but are universally recognized. This global alignment reinforces the validity and necessity of medication reconciliation as a core component of safe healthcare delivery worldwide, fostering the sharing of best practices and accelerating progress in patient safety across diverse healthcare systems.

Table 1: Chronology of Key Milestones in Medication Reconciliation

Year	Milestone	Significance
1960s-1970s	Early development of Electronic Health Records (EHRs)	Laid foundational technology for digital medication management.15
1992	Institute of Medicine advocates for electronic medical records	Highlighted inadequacies of paper systems and pushed for digital transformation.15
1999	IOM publishes “To Err Is Human: Building a Safer Health System”	Pivotal report shifting focus to systemic causes of medical errors, catalyzing patient safety movement.11
2004	Joint Commission announces MedRec as 8th National Patient Safety Goal	Formalized medication reconciliation as a critical safety mandate in U.S. hospitals.9
2006	Joint Commission begins surveying for MedRec compliance	Initiated accountability for hospitals to implement the NPSG.9
2009	Joint Commission stops surveying for MedRec compliance	Acknowledged widespread difficulties in implementation and compliance.9
2010	WHO High 5s Project initiates global MedRec implementation	Launched international efforts to standardize medication accuracy at care transitions (e.g., in France).13
September 2011	Joint Commission re-designates MedRec as 3rd NPSG	Re-emphasized the goal with a focus on “good faith effort” in collection and comparison.9

6. Evolution of Practice: From Manual Processes to Digital Integration

The historical trajectory of medication reconciliation reveals a profound transformation from rudimentary, paper-based methods to sophisticated digital systems, profoundly altering healthcare workflows and professional roles.

Historically, medication history gathering was often a fragmented and inconsistent process. Information was typically scattered across various sections of a patient’s paper chart, residing in nursing admission databases, medication administration records, and physician histories.³ This environment lacked a single, standardized “source of truth” for a patient’s comprehensive medication list.¹⁶ Manual processes were inherently prone to errors due to issues such as illegible handwriting, incomplete documentation, and the labor-intensive nature of cross-referencing multiple paper sources. Any changes to medication lists in paper formats necessitated manually crossing out old information and adding new entries, each requiring dating, timing, and signing.¹⁶ These manual burdens often led to significant workflow inefficiencies; for example, floor nurses were frequently tasked with acquiring medication and patient histories upon a patient’s arrival at an inpatient unit, which in turn delayed physicians in entering computerized provider order entry (CPOE) and performing the electronic medication reconciliation process.¹⁷ Such inefficiencies contributed to staff burnout and exacerbated time constraints within busy clinical environments.⁹

The inadequacies of paper records spurred a transformative shift towards electronic health records (EHRs) and digital solutions. The technological foundation for electronic medical records was laid in the 1960s and 1970s with the advent of new computer technology.¹⁵ By 1992, the Institute of Medicine formally advocated for a shift from paper-based to electronic medical records, recognizing the inherent limitations of traditional systems.¹⁵ The late 1980s and early 1990s witnessed a significant increase in the affordability and power of hardware, alongside the widespread adoption of personal computers, local area networks, and the internet. These advancements facilitated the emergence of web-based EHRs and provided significantly easier access to medical information.¹⁵

Electronic systems, exemplified by solutions like Surescripts, have revolutionized medication history management. These platforms enable the seamless surfacing of complete patient medication histories directly within EHR workflows, effectively replacing “tedious manual searches” and providing “easy access to accurate medication history information”.¹⁸ Such systems are capable of retrieving records from multiple locations in a standardized, quality-assured format, often in real-time and via a single connection.¹⁸ Studies have consistently demonstrated the feasibility and tangible benefits of electronic systems for medication reconciliation conducted by pharmacists and nurses during admission and discharge. These benefits include marked improvements in patient satisfaction with medication counseling and instructions.¹⁹ Patients whose medications were electronically reconciled reported a greater understanding of their post-discharge medications, encompassing administration instructions and potential adverse effects.²⁰

Despite their considerable advantages, the transition to electronic systems has also introduced new complexities and challenges. Current EHR vendor products often present specific problems with medication reconciliation software.¹⁰ These limitations include a lack of functionality to grade the quality of the pre-admission medication list (PAML) or its sources, which makes it difficult for downstream providers to fully trust the information.¹⁰ Furthermore, in many systems, medications in the PAML cannot be easily separated from their sources, potentially leading to confusion or misinterpretation.¹⁰ Misleading change descriptions can also arise if the system documents how discharge regimens differ from a PAML that is itself inaccurate.¹⁰ In some instances, providers may find workarounds, inadvertently bypassing crucial safety features embedded within the software.¹⁰ These issues highlight that while IT solutions are powerful tools, they are not panaceas and require meticulous design, careful implementation, and ongoing refinement to avoid creating new vulnerabilities. The observation that technology, while enhancing efficiency, can introduce new complexities underscores that its mere presence does not guarantee safety; rather, its thoughtful design and integration are paramount.

The formalization of medication reconciliation has fundamentally reshaped the roles and workflows of healthcare professionals, leading to clearer delineation of responsibilities and an increased emphasis on interdisciplinary collaboration.

• Pharmacists: The American Society of Health System Pharmacists (ASHP) strongly recommends direct involvement of pharmacists in developing policies, implementing processes, and training staff for medication reconciliation.² Pharmacists hold explicit responsibility for resolving discrepancies and verifying medication history lists before prescribing decisions are finalized, a critical task that cannot be delegated to non-pharmacist staff such as nurses or physicians.² Indeed, pharmacy-driven multidisciplinary processes have consistently demonstrated the highest net benefits in reducing medication errors within academic settings.⁹
• Pharmacy Technicians: With appropriate training, pharmacy technicians are now permitted to assist in gathering and documenting medication history to obtain the best possible medication history. However, their role is not independent; a supervising pharmacist must verify the medication history lists they collect.²
• Nurses: The roles of nurses have significantly evolved. Some facilities have implemented dedicated admission nurses responsible for obtaining the initial medication history directly in the emergency department, thereby streamlining the process for physicians by providing a more accurate and timely baseline.¹⁷ Nurses also play a vital role in verifying home medications with patients and providing essential patient education regarding their medication regimens.¹⁶
• Physicians: Within modern EHR workflows, physicians are prompted to complete medication reconciliation, documenting pre-admission medications and indicating their clinical decisions (e.g., continue, discontinue, modify) for each medication.¹⁶ Their ultimate responsibility lies in reviewing the reconciled list and determining the appropriateness of all medications for the patient’s current condition.⁹

This evolution of roles reflects a strategic organizational response to the demands of effective medication reconciliation. The increasing complexity of medication management and the regulatory mandates for reconciliation have necessitated a clearer division of labor and a greater emphasis on collaborative care. The explicit roles of pharmacists in verification and policy, pharmacy technicians in data gathering, and the emergence of specialized admission nurses are direct responses to the previously identified high error rates in informal history-taking. This division of labor and the emphasis on verification by specific professionals represent a systemic response designed to improve accuracy, signifying a maturation in healthcare delivery that moves beyond fragmented, informal practices to a more structured, team-based approach for critical patient safety processes.

7. Measurable Impact: Patient Safety Outcomes and Healthcare Efficiency

The formalization and widespread implementation of medication reconciliation have yielded compelling evidence of its tangible benefits, significantly improving patient safety outcomes and enhancing healthcare efficiency.

Formal medication reconciliation processes have been demonstrably effective in substantially lowering the incidence of medication errors that often arise from incomplete or inaccurate medication histories.²¹ A multidisciplinary approach, particularly when driven by pharmacy expertise, has shown the highest net benefits in reducing medication errors in academic settings.⁹ Quantitative studies provide robust evidence of these reductions. One project achieved a 20% reduction in patients with at least one outstanding unintentional discrepancy at admission (decreasing from 27% to 7%) and a 12% reduction at discharge (from 17% to 5%).²¹ This resulted in a mean reduction of 0.74 discrepancies per patient at admission.²¹ The WHO High 5s project in Australian hospitals, through its sustainable medication reconciliation process, achieved measurable improvements in the accuracy of medication information upon admission. The mean number of unintentional medication discrepancies per patient decreased from 0.21 to 0.16, and overall unintentional discrepancies decreased from 15.2% to 11.1%.²¹ Furthermore, a series of interventions that included medication reconciliation successfully decreased the rate of medication errors by 70% and reduced adverse drug events (ADEs) by over 15% within a seven-month period.²¹ French experimentation with the WHO High 5s project from 2010-2014 reported the interception and correction of a mean of 0.9 medication errors per patient, all resolved through collaborative efforts between pharmacists and physicians.¹³ The consistent positive outcomes across various studies and initiatives provide a strong, evidence-based argument for the efficacy and necessity of medication reconciliation. This data serves as a powerful justification for continued investment and optimization of these processes, demonstrating a clear return on investment in terms of both patient well-being and healthcare economics.

Beyond direct error reduction, medication reconciliation contributes significantly to improved hospital utilization and reduced healthcare costs. Its implementation has been linked to reductions in the length of hospital stay, decreased patient readmissions, and overall lower healthcare expenditures.²¹ A comprehensive package of discharge services that incorporated medication reconciliation was specifically shown to reduce hospital usage within 30 days of discharge.²¹ Additionally, the adoption of electronic medication history solutions for reconciliation has demonstrated efficiency gains by replacing time-consuming manual searches, further contributing to cost savings and streamlined operations.¹⁸

Despite these substantial advancements, medication reconciliation remains a complex process, and failures can still lead to significant clinical consequences. Studies indicate that up to 91% of medication reconciliation errors are clinically significant, with a concerning 1–2% being serious or potentially life-threatening.⁸ A detailed study of serious events reported to the Pennsylvania Patient Safety Reporting System (PA-PSRS) between 2015 and 2020 identified 93 serious events directly related to medication reconciliation failures. The majority of these events (58.1%) resulted in temporary harm requiring treatment or intervention, and a tragic 3.3% led to permanent harm or death.⁸ The study further pinpointed admission/triage as the most frequent transition of care associated with these serious events (69.9%), and order entry/transcription as the most common stage of process failure (41.9%), often resulting in wrong dose or dose omission.⁸ Most serious events were discovered only after a change in the patient’s condition (76.3%) and frequently necessitated readmission, emergency care, intensive care, or transfer to a higher level of care (58%).⁸ The ability to pinpoint specific “vulnerable moments” and stages of failure, even after formal processes are in place, highlights that medication reconciliation is an ongoing quality improvement journey, not a static achievement. These persistent vulnerabilities underscore the need for continuous monitoring, targeted interventions (e.g., improved CPOE design, enhanced training for admission staff), and potentially more robust technological or human safeguards to move closer to the goal of zero harm.

Table 2: Impact of Medication Reconciliation on Patient Safety Metrics

Metric	Impact/Finding	Source
Reduction in Unintentional Discrepancies	20% reduction at admission (from 27% to 7%) and 12% reduction at discharge (from 17% to 5%) in one study. Mean reduction of 0.74 discrepancies per patient at admission.	21
	WHO High 5s: Mean unintentional discrepancies per patient decreased from 0.21 to 0.16; overall unintentional discrepancies decreased from 15.2% to 11.1%.	21
Reduction in Medication Errors	70% reduction in one study.	21
	French WHO High 5s: Mean of 0.9 intercepted and corrected medication errors per patient.	13
Reduction in Adverse Drug Events (ADEs)	>15% reduction in one study.	21
Impact on Hospital Utilization	Reductions in length of hospital stay, patient readmissions, and healthcare costs. Discharge services including MedRec reduced 30-day hospital usage.	21
Clinical Significance of Errors	Up to 91% of MedRec errors are clinically significant; 1-2% are serious or potentially life-threatening.	8
Serious Harm Incidents (PA-PSRS Study, 2015-2020)	93 serious events identified; 58.1% resulted in temporary harm; 3.3% resulted in permanent harm or death.	8
Common Failure Points (PA-PSRS Study)	Admission/triage was the most frequent transition of care associated with events (69.9%). Order entry/transcription was the most common stage of process failure (41.9%), often resulting in wrong dose or dose omission.	8

8. Persistent Challenges and Future Directions

Despite significant advancements and the demonstrable benefits of formalized medication reconciliation, its effective implementation continues to face a multitude of complexities and barriers. These enduring challenges necessitate ongoing vigilance and adaptive strategies to achieve optimal patient safety outcomes.

A primary hurdle lies in the systemic complexities and cultural resistance inherent in healthcare organizations. Medication reconciliation is an inherently complex and resource-intensive process, often encountering resistance to change from both existing system structures and ingrained hierarchical hospital cultures.⁸ A lack of robust institutional support frequently predicts the failure of quality improvement initiatives.¹⁰ This is compounded by persistent time and resource constraints, including insufficient personnel and financial investment, particularly for obtaining a thorough Best Possible Medication History (BPMH).⁷

Challenges in obtaining accurate medication histories remain significant. Patients and their families often have a poor understanding of their medication regimens or are unable to communicate effectively at the time of admission.³ Patients frequently do not bring their pill bottles or accurate medication lists to the hospital.⁹ The fragmented nature of the medical system means there is often no single “source of truth” for medication information, and providers may inadvertently rely on outdated sources.¹⁰ Furthermore, a lack of standardized approaches to taking medication histories persists in many settings.³

Workflow integration issues also pose considerable difficulties. Integrating new protocols into established clinical workflows can be challenging, particularly if they interrupt existing patterns of practice.¹⁰ For instance, traditional workflows that placed the burden of history-taking on floor nurses often delayed physicians in their subsequent tasks.¹⁷ Moreover,

Information Technology (IT) limitations within many EHR systems continue to present problems for medication reconciliation software. These include the inability to grade the quality of medication lists, to separate the PAML from its original sources, or to provide accurate descriptions of medication changes, which can inadvertently lead providers to bypass safety features within the system.¹⁰

Finally, behavioral and cultural barriers are substantial. A significant challenge is the lack of buy-in from providers and patients who may not fully appreciate the critical need for change. Medication reconciliation can be stigmatized as merely a regulatory requirement rather than a fundamental clinical imperative for patient safety.¹⁰ These deeply ingrained human behaviors, organizational cultures, and the inherent complexity of healthcare systems mean that many persistent challenges are not easily solved by a single technical intervention. The need for strategies to change perceptions underscores that these are not merely technical problems but socio-cultural and organizational ones.

Table 3: Common Challenges and Corresponding Mitigation Strategies in Medication Reconciliation

Challenge	Mitigation Strategy	Source
Lack of Institutional Support/Buy-in	Secure strong senior leadership commitment and foster on-site champions.	10
Time and Resource Constraints	Form multidisciplinary teams with clear role definitions; allocate sufficient personnel and financial resources.	8
Patient/Family Poor Understanding or Inability to Provide Accurate History	Actively engage and educate patients and families on the importance of maintaining and carrying an accurate medication list.	9
Fragmented Medical Systems/Lack of “One Source of Truth”	Standardize and simplify processes by developing a single, shared medication list (“One Source of Truth”).	16
IT Software Limitations (e.g., quality grading, bypassing safety features)	Strategically leverage technology with thoughtful design, ensuring systems facilitate “One Source of Truth,” integrate seamlessly, and provide clear documentation.	10
Cultural Resistance to Change/Stigma	Implement comprehensive, ongoing, multidisciplinary staff education and training, emphasizing the clinical importance and holistic patient view.	9
Workflow Inefficiencies	Redesign workflows to integrate reconciliation seamlessly, potentially using dedicated roles (e.g., admission nurses) and process improvement methodologies.	10
Inadequate Measurement and Data Collection	Implement phased approaches and continuous monitoring with core measures; utilize quality improvement methodologies.	14

Strategies and Recommendations for Continuous Improvement

To overcome these persistent challenges and advance medication reconciliation towards the goal of zero harm, several strategic recommendations are critical:

1. Interdisciplinary Approach and Clear Roles: Successful implementation mandates a robust interdisciplinary approach with clearly defined roles and responsibilities for all healthcare professionals involved, including pharmacists, nurses, and technicians.⁸ Pharmacy-driven processes have consistently demonstrated superior benefits.⁹
2. Standardization and Simplification: Developing a single, shared medication list, often referred to as a “One Source of Truth,” and standardizing/simplifying the reconciliation process across the entire organization can eliminate redundancies and significantly improve consistency.¹⁶
3. Patient and Family Engagement: Actively involving patients and their families in the process is paramount for obtaining accurate information and ensuring their understanding of medication changes and discharge instructions.⁹ Patients should be educated on the importance of maintaining and carrying an accurate, updated medication list.⁹
4. Comprehensive Education and Training: Multidisciplinary educational programs are key to success, focusing not only on enhanced medication history-taking skills but also on critical thinking and the importance of viewing the patient holistically within their medication regimen.⁹
5. Leveraging Technology Effectively: While IT presents challenges, it is essential to design electronic systems that truly facilitate the “One Source of Truth,” integrate seamlessly into clinical workflows, provide intelligent prompts, and allow for clear, traceable documentation of changes and information sources.¹⁶ Continuous refinement of EHR features based on user feedback and observed errors is necessary.
6. Process Improvement Methodologies: Adopting industry-proven process improvement methods such as Lean, Six Sigma, and change management can prove more effective than a rigid “one-size-fits-all” approach.¹¹ These methodologies encourage iterative improvement and adaptation.
7. Phased Implementation and Continuous Monitoring: Starting with small, manageable tests of change, collecting baseline data, and continuously evaluating the process with core measures (as outlined by the WHO High 5s Project) allows for iterative improvement and sustained gains.¹⁴ Unwavering senior leadership commitment and the presence of dedicated on-site champions are vital for long-term success.¹⁴

The enduring complexity of human and systemic factors necessitates holistic solutions that extend beyond solely technical interventions. Future efforts in medication reconciliation must address the socio-cultural and organizational determinants of success, implying a need for robust change management strategies, continuous education, and unwavering leadership commitment. This approach fosters a pervasive culture of safety where medication reconciliation is viewed as a shared responsibility and a clinical imperative, not merely a regulatory checklist item. The imperative for adaptive, iterative improvement in a dynamic healthcare landscape is clear. The recommendation for “phased implementation” and “small tests of change” by the WHO High 5s project ¹⁴, coupled with the advocacy for “Lean, Six Sigma and change management” ¹¹, highlights the ineffectiveness of static solutions. This suggests that successful medication reconciliation is not a fixed process but requires continuous adaptation, learning from failures, and iterative refinement based on local contexts and ongoing data. The identification of specific failure points further emphasizes the need for targeted, adaptive interventions. The future of medication reconciliation lies in adopting agile, quality improvement methodologies that allow healthcare organizations to continuously identify and address emergent challenges, optimize workflows, and integrate new technologies effectively. This iterative approach, coupled with a commitment to learning from both successes and failures, is crucial for achieving the ultimate goal of “zero harm” in medication management in an ever-evolving healthcare environment.

9. Conclusion

The history of medication reconciliation is a compelling narrative of healthcare’s evolving understanding of patient safety and its unwavering commitment to mitigating preventable harm. From ancient, informal practices of documenting medicinal treatments to the sophisticated, digitally integrated processes of today, the journey reflects a continuous striving for accuracy and safety in medication management. The pivotal “To Err Is Human” report served as a catalyst, fundamentally shifting the paradigm from individual blame to systemic accountability, thereby legitimizing and accelerating the need for formal, standardized interventions. Regulatory bodies like The Joint Commission and global initiatives such as the WHO High 5s Project have played indispensable roles in mandating and harmonizing these processes, underscoring the universal imperative for medication accuracy at critical transitions of care.

The transformation from manual, error-prone methods to electronic systems has demonstrably reduced medication errors, adverse drug events, and healthcare costs, while also fostering greater interdisciplinary collaboration and defining specialized roles for healthcare professionals. However, the journey is far from complete. Persistent challenges rooted in systemic complexities, workflow integration, IT limitations, and cultural resistance continue to demand attention. The ongoing occurrence of serious medication reconciliation failures highlights that despite significant progress, specific high-risk areas and process stages remain vulnerable.

Ultimately, the evolution of medication reconciliation stands as a testament to the healthcare system’s ongoing commitment to patient safety. It is a dynamic and evolving process that requires continuous vigilance, adaptive strategies, and a relentless pursuit of innovation. Achieving the ultimate goal of zero harm in medication management necessitates a holistic approach that addresses not only technological solutions but also cultural shifts, robust training, and iterative process improvement, ensuring that every patient receives the right medication, at the right dose, at the right time.

Works cited

1. www.ncbi.nlm.nih.gov, accessed August 18, 2025, https://www.ncbi.nlm.nih.gov/books/NBK2648/#:~:text=According%20to%20the%20Joint%20Commission,dosing%20errors%2C%20or%20drug%20interactions.
2. Oregon Board of Pharmacy : Medication Reconciliation : State of …, accessed August 18, 2025, https://www.oregon.gov/pharmacy/pages/medication-reconciliation.aspx
3. Medication Reconciliation – Patient Safety and Quality – NCBI Bookshelf, accessed August 18, 2025, https://www.ncbi.nlm.nih.gov/books/NBK2648/
4. The History of Pharmacy | Texas Tech University Health Sciences Center, accessed August 18, 2025, https://www.ttuhsc.edu/pharmacy/museum/pharmacy.history.aspx
5. A Look into the History and Evolution of Medical Documentation | CKEditor, accessed August 18, 2025, https://ckeditor.com/blog/history-of-medical-documentation/
6. History of pharmacy – Wikipedia, accessed August 18, 2025, https://en.wikipedia.org/wiki/History_of_pharmacy
7. Ascertaining Problems with Medication Histories – PMC – PubMed Central, accessed August 18, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC3477833/
8. Medication Reconciliation Process Failures: – PATIENT SAFETY, accessed August 18, 2025, https://patientsafetyj.com/api/v1/articles/73535-patient-harm-resulting-from-medication-reconciliation-process-failures-a-study-of-serious-events-reported-by-pennsylvania-hospitals.pdf
9. Overcoming the pitfalls of medication reconciliation | NSO, accessed August 18, 2025, https://www.nso.com/Learning/Artifacts/Articles/defensive-documentation-2
10. MARQUIS IMPLEMENTATION MANUAL – Society of Hospital Medicine, accessed August 18, 2025, https://www.hospitalmedicine.org/globalassets/clinical-topics/clinical-pdf/shm_medication_reconciliation_guide.pdf
11. Revisiting To Err Is Human 20 years later | ACS, accessed August 18, 2025, https://www.facs.org/for-medical-professionals/news-publications/news-and-articles/bulletin/2020/02/revisiting-to-err-is-human-20-years-later/
12. To Err is Human: Building a Safer Health System – PubMed, accessed August 18, 2025, https://pubmed.ncbi.nlm.nih.gov/25077248/
13. (PDF) High 5s initiative: implementation of medication reconciliation in France a 5 years experimentation – ResearchGate, accessed August 18, 2025, https://www.researchgate.net/publication/317804201_High_5s_initiative_implementation_of_medication_reconciliation_in_France_a_5_years_experimentation
14. Table of Contents – World Health Organization (WHO), accessed August 18, 2025, https://cdn.who.int/media/docs/default-source/patient-safety/high5s/h5s-guide.pdf
15. Electronic Health Records: Then, Now, and in the Future – PMC – PubMed Central, accessed August 18, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC5171496/
16. Chapter 3. Developing Change: Designing the Medication … – AHRQ, accessed August 18, 2025, https://www.ahrq.gov/patient-safety/settings/hospital/match/chapter-3.html
17. Decreasing Medication Reconciliation Challenges One Admission …, accessed August 18, 2025, https://www.aha.org/case-studies/2015-06-17-decreasing-medication-reconciliation-challenges-one-admission-nurse-time
18. Medication History for Reconciliation | Surescripts, accessed August 18, 2025, https://surescripts.com/what-we-do/medication-history-for-reconciliation
19. Implementation of an electronic system for medication reconciliation – Oxford Academic, accessed August 18, 2025, https://academic.oup.com/ajhp/article/64/4/404/5135129?itm_medium=sidebar&itm_source=trendmd-widget&itm_campaign=American_Journal_of_Health-System_Pharmacy&itm_content=American_Journal_of_Health-System_Pharmacy_0
20. Implementation of an electronic system for medication reconciliation – PubMed, accessed August 18, 2025, https://pubmed.ncbi.nlm.nih.gov/17299180/
21. Implementation of medication reconciliation at admission and …, accessed August 18, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC10277137/